GlassScriptPhysician profile
Brittany Senff
NPI 1346641909
$4,243.26
in general payments reported to CMS, 2019-2025
31 companies · $607 in 2025
The $607 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,112 · 2022: $1,119 · 2023: $656 · 2024: $749 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,011.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,133.84 | 2021-2025 | |
| Amgen INC. | $587.57 | 2021-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $491.93 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Corium, LLC | $219.47 | 2023-2024 | Azstarys |
| Lilly USA, LLC | $162.63 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $154.37 | 2021-2023 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.35 | 2021-2024 | Jardiance, Tradjenta |
| Merck Sharp & Dohme LLC | $132.21 | 2021-2025 | Gardasil 9, Capvaxive, M-M-R II |
| Otsuka America Pharmaceutical, INC. | $118.10 | 2022-2024 | Rexulti, Abilify Maintena |
| Idorsia Pharmaceuticals US INC | $110.14 | 2022-2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $102.46 | 2025 | |
| Lundbeck LLC | $101.95 | 2021-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $89.08 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $79.08 | 2021-2022 | |
| Edwards Lifesciences Corporation | $68.78 | 2024 | Sapien 3 Ultra Resilia |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $66.85 | 2021-2022 | |
| Glaxosmithkline, LLC. | $65.36 | 2022-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbott Laboratories | $53.86 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Amarin Pharma, INC. | $48.41 | 2022-2023 | |
| Almatica Pharma LLC | $39.50 | 2024 | Loreev Xr, Teriparatide |
| Eisai INC. | $35.03 | 2021-2022 | |
| Pfizer INC. | $33.26 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $30.09 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $29.20 | 2023 | Evkeeza |
| Exact Sciences Corporation | $27.15 | 2023-2025 | Cologuard Collection Kit |
| Azurity Pharmaceuticals, INC. | $23.34 | 2023 | Edarbyclor |
| Genentech USA, INC. | $23.17 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.18 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.15 | 2022 | |
| Bausch Health US, LLC | $14.86 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Senff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.